---
title: Real-world management of patients with complete response under immune-checkpoint
  inhibition for advanced melanoma
date: '2025-01-03'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39748658/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20250103170653&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSIONS: There are significant differences between the centers regarding
  staging intervals and duration of ICI upon CR. Prospective studies are necessary
  to determine the optimal time point of ICI discontinuation and ...'
disable_comments: true
---
CONCLUSIONS: There are significant differences between the centers regarding staging intervals and duration of ICI upon CR. Prospective studies are necessary to determine the optimal time point of ICI discontinuation and ...